Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-044219
Filing Date
2017-08-18
Accepted
2017-08-18 17:22:06
Documents
82
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v472578_10q.htm 10-Q 544853
2 EXHIBIT 31.1 v472578_ex31-1.htm EX-31.1 11561
3 EXHIBIT 32.1 v472578_ex32-1.htm EX-32.1 4530
  Complete submission text file 0001144204-17-044219.txt   7954083

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT prgb-20170630.xml EX-101.INS 1949349
5 XBRL TAXONOMY EXTENSION SCHEMA prgb-20170630.xsd EX-101.SCH 89494
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prgb-20170630_cal.xml EX-101.CAL 48916
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prgb-20170630_def.xml EX-101.DEF 548845
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE prgb-20170630_lab.xml EX-101.LAB 556264
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prgb-20170630_pre.xml EX-101.PRE 589888
Mailing Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505
Business Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505 304 292-2226
Protea Biosciences Group, Inc. (Filer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51474 | Film No.: 171041727
SIC: 2834 Pharmaceutical Preparations